Pharmafile Logo

Accelerated Access Review

- PMLiVE

Lucid Group Achieve UK’s Highest Award for Business Success

Lucid Group have been chosen to receive a Queen’s Award for Enterprise in International Trade. This award is widely regarded as the UK’s highest accolade for business success and they...

Lucid Group Communications Limited

National Institute for Health and Care Excellence NICE logo

NICE turns down Opdivo for head and neck cancer

BMS’s nivolumab proves too costly for the NHS

- PMLiVE

Focus on value: A prescription for pharma

The pricing debate demands a common language to be developed

- PMLiVE

Snapchat arrives at scientific meetings

And NICE becomes the first public health body to use the platform

National Institute for Health and Care Excellence NICE logo

NICE knocks-back Shire’s pancreatic cancer drug Onivyde

Final guidance rules it's not a cost-effective use of NHS resources

Getting the most out of your agency – a guide to developing a dynamic and rewarding relationship with your agency partner

A high proportion of pharma and biotech marketing budget is spent on medical communications agencies. In fact, over the years the size of this service industry has grown enormously and is...

Porterhouse Medical Group

Bring some #LucidLife to your medical education programmes

Meet Madeleine, an Account Director.Madeleine understands the importance of improving patient outcomes and has played a pivotal part in developing many of our award-winning behaviour-change programmes.Our people are our biggest...

Lucid Group Communications Limited

Biogen Idec building

NICE backtracks on Biogen’s multiple sclerosis drug Zinbryta

Recommends the treatment after new cost effectiveness and a discount provided

National Institute for Health and Care Excellence NICE logo

NICE agrees £20m cost ceiling for new drugs

New budget test set to begin from April and could delay uptake of new medicines

- PMLiVE

Lucid Group gains further momentum with launch of new Strategic Consultancy

Lucid Group has made an exciting company expansion with the launch of the new Lucid Strategic Consultancy and the appointment of Duncan Ferguson as MD.Duncan Ferguson is highly qualified for...

Lucid Group Communications Limited

- PMLiVE

NICE set to back Parsabiv for kidney disease complication

Draft guidance recommends Amgen treatment for secondary hyperparathyroidism

- PMLiVE

NICE turns down first-line Keytruda for lung cancer

High cost of drug puts it above cost-effectiveness threshold

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links